Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Azuma

Showing results (31-40 of 413) with videos related to

Pageof 42
Sort By:
Annals of Ophthalmology|October 1, 1977
Diurnal variations in outflow facilityY Takeda, I Azuma
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Antitumor activity of bacterial fractions and related synthetic compounds]I Azuma, Y Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1974
[Immunotherapy of cancer with BCG]Y Yamamura, I Azuma
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 1, 1978
[Cancer immunotherapy with BCG cell-wall skeleton (author's transl)]I Azuma, Y Yamamura
Cancer Treatment Reviews|September 1, 1981
Experimental and clinical evaluation of cancer immunotherapeuticsI Azuma, Y Sakurai
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1981
[Chemical synthesis and immunologic activities of the active unit of BCG-CWS]I Saiki, I Azuma
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1980
[BCG vaccine in cancer immunotherapy]I Azuma, I Saiki
International Immunopharmacology|July 20, 2001
Development of immunoadjuvants for immunotherapy of cancerI Azuma, T Seya
Nihon Ganka Kiyo|August 1, 1970
[Effects of Ubretid eye-drops upon glaucoma]T Mizukawa, I Azuma
Medicinal Research Reviews|July 1, 1994
Potentiation of host defense mechanism against infection by a cytokine inducer, an acyl-MDP derivative, MDP-Lys(L18) (romurtide) in mice and humansI Azuma, T Otani
Pageof 42

Showing results (31-40 of 413) with videos related to

Sort By:
Pageof 42
Annals of Ophthalmology|October 1, 1977
Diurnal variations in outflow facilityY Takeda, I Azuma
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1984
[Antitumor activity of bacterial fractions and related synthetic compounds]I Azuma, Y Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1974
[Immunotherapy of cancer with BCG]Y Yamamura, I Azuma
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|May 1, 1978
[Cancer immunotherapy with BCG cell-wall skeleton (author's transl)]I Azuma, Y Yamamura
Cancer Treatment Reviews|September 1, 1981
Experimental and clinical evaluation of cancer immunotherapeuticsI Azuma, Y Sakurai
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1981
[Chemical synthesis and immunologic activities of the active unit of BCG-CWS]I Saiki, I Azuma
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1980
[BCG vaccine in cancer immunotherapy]I Azuma, I Saiki
International Immunopharmacology|July 20, 2001
Development of immunoadjuvants for immunotherapy of cancerI Azuma, T Seya
Nihon Ganka Kiyo|August 1, 1970
[Effects of Ubretid eye-drops upon glaucoma]T Mizukawa, I Azuma
Medicinal Research Reviews|July 1, 1994
Potentiation of host defense mechanism against infection by a cytokine inducer, an acyl-MDP derivative, MDP-Lys(L18) (romurtide) in mice and humansI Azuma, T Otani
Pageof 42